NCT04680585

Brief Summary

Despite available treatments for perinatal mood disorders, only 20% of affected women receive treatment that results in remission of symptoms. In order to address gaps in equitable access to treatment the investigators developed the Reproductive Mental health of Ontario Virtual Intervention Network (MOVIN), a virtual collaborative care platform to optimize access for pregnant and postpartum people in Ontario. MOVIN combines collaborative and stepped-care approaches to treatment of perinatal depression and anxiety. The overall objective of this pilot randomized controlled trial (RCT) is to determine the feasibility of implementing a protocol for studying MOVIN for pregnant and postpartum individuals with significant symptoms of depression and anxiety (EPDS \> 12) in order to inform the conduct of a larger scale evaluation. O will be randomized to either the MOVIN or control condition and will be asked to complete follow-up assessments 12- and 24-weeks post-randomization. Participants in the MOVIN arm will receive access to the MOVIN platform which includes a care coordinator to help them navigate various virtual treatments. Participants in the control condition will receive a resource list and will navigate the various options on their own.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
101

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 7, 2020

Completed
16 days until next milestone

First Posted

Study publicly available on registry

December 23, 2020

Completed
4 months until next milestone

Study Start

First participant enrolled

April 12, 2021

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2022

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2022

Completed
Last Updated

May 28, 2025

Status Verified

May 1, 2025

Enrollment Period

1.2 years

First QC Date

December 7, 2020

Last Update Submit

May 21, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • Feasibility of the trial protocol: Recruitment

    Measures of recruitment and retention include rate of recruitment, reason for non-participation and rate of completion of follow-up measures.

    12 weeks post randomization

  • Feasibility of the trial protocol: Acceptability

    Measures of acceptability include participants' overall experience and satisfaction with and acceptance of the MOVIN platform and the care coordinator, the care coordinator's assessment of the MOVIN platform and its impact on patient care, and primary care providers' assessment of MOVIN's impact on patient care.

    12 weeks post randomization

  • Feasibility of the trial protocol: Compliance

    Measures of compliance include rate of completion of MOVIN-specific activities, rate of completion of suggested interventions, and rate of resource use.

    12 weeks post randomization

Secondary Outcomes (14)

  • Feasibility of the trial protocol: Recruitment

    24 weeks post randomization

  • Feasibility of the trial protocol: Acceptability

    24 weeks post randomization

  • Feasibility of the trial protocol: Compliance

    24 weeks post randomization

  • Maternal clinical outcomes - depression symptoms

    12 and 24 weeks post randomization

  • Maternal clinical outcomes - anxiety symptoms

    12 and 24 weeks post randomization

  • +9 more secondary outcomes

Other Outcomes (3)

  • Co-variates

    Baseline

  • Maternal birth outcomes

    Baseline, 12 and 24 weeks post randomization

  • Neonatal birth outcomes

    Baseline, 12 and 24 weeks post randomization

Study Arms (2)

Enhanced Usual Care

OTHER

Access to online resources and educational materials about general mental health, maternal mental health, depression and anxiety in the pregnancy and postpartum period, and an up-to-date listing of treatment services available in Ontario. These resources are maintained by the MOVIN study team.

Other: Enhanced Usual Care

MOVIN

EXPERIMENTAL

Enhanced Usual Care plus MOVIN Care Platform. The MOVIN Care Platform is virtual collaborative care intervention with a stepped care approach in which a care coordinator directs participants to one or more evidence-based virtual interventions as appropriate.

Other: Enhanced Usual CareOther: MOVIN Care Platform

Interventions

A standardized handout with information on what treatment options might be useful to start with based on EPDS score and stage of pregnancy or postpartum.

Enhanced Usual CareMOVIN

Virtual collaborative care intervention with a stepped care approach in which a care coordinator directs participants to one or more evidence-based virtual interventions as appropriate.

MOVIN

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Residents of Ontario at least 18 years of age
  • Currently pregnant or mother\* of a live infant 0-12 months of age living at the same residence \*through natural birth, adoption or surrogacy, including cis women, non-binary and transgender people in all their diversity
  • EPDS \> 12
  • Registered with a primary care provider

You may not qualify if:

  • Experiencing active suicidal ideation (MINI International Neuropsychiatric Interview)
  • Active substance use disorder (GAIN-SS), current mania or psychosis (MINI Neuropsychiatric Interview)
  • Unable to access the internet or a device that can support the MOVIN platform
  • Unable to participate in English
  • Unable to provide informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Women's College Hospital

Toronto, Ontario, M5S1B2, Canada

Location

MeSH Terms

Conditions

Depression, Postpartum

Condition Hierarchy (Ancestors)

Puerperal DisordersPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDepressive DisorderMood DisordersMental Disorders

Study Officials

  • Ariel Dalfen, MD

    Women's College Hospital and Sinai Health System

    PRINCIPAL INVESTIGATOR
  • Simone Vigod, MD, MSc

    Women's College Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief, Department of Psychiatry

Study Record Dates

First Submitted

December 7, 2020

First Posted

December 23, 2020

Study Start

April 12, 2021

Primary Completion

June 30, 2022

Study Completion

December 30, 2022

Last Updated

May 28, 2025

Record last verified: 2025-05

Locations